GlassScriptPhysician profile
Nathan Rech
NPI 1992150023
$7,157.98
in general payments reported to CMS, 2019-2025
16 companies · $594 in 2025
The $594 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,238 · 2022: $2,660 · 2023: $827 · 2024: $1,839 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,943 · Travel and Lodging: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,943.13 |
| Travel and Lodging | $1,317.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $3,429.03 | 2021-2024 | |
| Arthrex, INC. | $1,381.83 | 2023-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $1,274.85 | 2022-2023 | |
| Stryker Corporation | $258.55 | 2022-2025 | Prophecy, Citrefix, Prostep |
| Acumed LLC | $146.54 | 2025 | Acumed |
| Davol INC. | $144.96 | 2022 | |
| Nexus Medical Technologies LLC | $127.29 | 2025 | |
| Smith+Nephew, INC. | $117.25 | 2022-2025 | Uni Cp, Memofix Super Elastic Nitinol Staple System, Cadence |
| Integra Lifesciences Corporation | $70.88 | 2023 | Tenoglide |
| Flower Orthopedics Coporation | $59.95 | 2023 | |
| Becton, Dickinson and Company | $40.67 | 2024 | Arista Ah Flexitip |
| Argentum Medical | $30.33 | 2021 | |
| Arteriocyte Medical Systems, INC. | $23.57 | 2024 | Magellan |
| Globus Medical, INC. | $22.87 | 2025 | Ossifuse, Affirm, Osteocel |
| Paragon 28, INC. | $18.09 | 2023 | Silverback |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $11.32 | 2025 | Accelstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Rech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.